PATENT CLAIM ANALYSIS

Application Number: 16297354
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "04400A"]

Abstract:
This invention relates to compounds, compositions, and methods useful for reducing Glycolate Oxidase (HAO1) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Claim (Index 114):
The method of  claim 109 , wherein administration of the nucleic acid to the subject is performed subcutaneously.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15793441', '14583200', '15616254', '16297316', '16168671']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9254916319562636
- 35 USC 102 Novelty (BERT): 0.6659567244439748
- Combined Prediction Score: 0.8995381412050348
- Mean Citation Score: 910.7023319999996
- Max Citation Score: 971.7144
- Similarity Product: 637.1613257678033

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test